NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Clinical trial NCT01733121 · COMPLETED
Trial details
- NCT number
- NCT01733121
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2013-12-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.